57. 特発性拡張型心筋症 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 11 / 薬物数 : 17 - (DrugBank : 10) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 35

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Allopurinol
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Benazepril
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Bone marrow mononuclear cells
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom
Carvedilol
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
Coenzyme Q10
   University of Tehran
      2006   Phase 4   NCT02115581   Iran, Islamic Republic of
Dobutamine
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Granulocyte colony stimulating factor
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom
Honey
   mamdouh abdulmaksoud abdulrhman
      2015   Phase 2/Phase 3   NCT02987322   -
Htea
   Harbin Medical University
      2013   -   NCT02292043   China
Infusion OF autologous mononuclear bone marrow cells
   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
      2014   Phase 2   NCT02033278   Spain
Lenograstim
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom
Metoprolol
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Metoprolol succinate + doxazosin
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
Mono nuclear cell (MNC) transplantation
   Nasser Aghdami MD., PhD
      2013   Phase 1/Phase 2   NCT02256501   Iran, Islamic Republic of
Umbilical cord mesenchymal stem cells
   Qingdao University
      2010   Phase 1/Phase 2   NCT01219452   China
Valsartan
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Water
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom